Denitsa Milanova

Presidente en Marble Therapeutics, Inc. .

39 años

Consumer Services

Commercial Services

Perfil

Denitsa M.
Milanova is an Independent Non-Executive Director at InSilico Medicine Cayman TopCo and holds the positions of President, Treasurer, Director & Vice President at Marble Therapeutics, Inc. She received her doctorate degree from Stanford University in 2016 and her undergraduate degree from the University of Central Florida in 2008.

Cargos activos de Denitsa Milanova

Empresas	Cargo	Inicio
Insilico Medicine Cayman TopCo Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong.	Director/Miembro de la Junta	01/06/2023
Marble Therapeutics, Inc. Marble Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Marble Therapeutics, Inc. develops gene therapies. The company is based in Boston, MA.	Presidente	-

Todos los cargos activos de Denitsa Milanova

Formación de Denitsa Milanova.

Stanford University	Doctorate Degree
University of Central Florida	Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Denitsa Milanova.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Insilico Medicine Cayman TopCo Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong.	Commercial Services
Marble Therapeutics, Inc. Marble Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Marble Therapeutics, Inc. develops gene therapies. The company is based in Boston, MA.	Commercial Services